Skip to main content
Previous Poster Home Next

Treatment of HER2+ Breast Cancer: A Retrospective of Disease Prognosis With Loss of HER2 Amplification on Residual Disease After Neoadjuvant Treatment in a Community Hospital Setting
07:30am - 03:45pm EST - March 31, 2023

  • Information
  • Resources
  • Play Recording

Treatment of HER2+ Breast Cancer: A Retrospective of Disease Prognosis With Loss of HER2 Amplification on Residual Disease After Neoadjuvant Treatment in a Community Hospital Setting icon

Treatment of HER2+ Breast Cancer: A Retrospective of Disease Prognosis With Loss of HER2 Amplification on Residual Disease After Neoadjuvant Treatment in a Community Hospital Setting


Author(s):
  • Dr. Dariusz Uczkowski, MD, Internal Medicine Resident PGY2, Atlantic Health System Inc.

Tags: Clinical Oncology

Display Label Action
AC23P34 - Treatment of HER2+ Breast Cancer: A Retrospective of Disease Prognosis With Loss of HER2 Amplification on Residual Disease After Neoadjuvant Treatment in a Community Hospital Setting Download MP3
HER2 NCCN.pdf Download Resource